Clinical trial
Effects of Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients. A Prospective Randomized Controlled Study
NCT01458808 is registered in ClinicalTrials.gov with UPECLIN HC FM Botucatu Unesp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients. A Prospective Randomized Controlled Study
- Lead sponsor
- UPECLIN HC FM Botucatu Unesp
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- February 28, 2009
- Enrollment
- 59 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney diseases stage 5